FABRAZYME Powder for Concentrate for Solution for Infusion
Agalsidase beta
5 mg/ml
BAYER CONSUMER CARE
| Pack size | 1 Vial (7 ml) |
|---|---|
| Dispensing mode | |
| Source | |
| Agent | |
| Retail Price | 14909.65 AED |
Available as:
Indications
FABRAZYME Powder for Concentrate for Solution for Infusion is used for:
For treatment of Fabry's disease (alpha-galactosidase A deficiency)
Adult Dose
Child Dose
Renal Dose
Administration
Contra Indications
Precautions
Pregnancy-Lactation
Interactions
Adverse Effects
Side effects of Agalsidase beta :
Mechanism of Action
Alpha-galactosidase A catalyzes the hydrolysis of globotriaosylceramide (GL-3) and other a-galactyl-terminated neutral glycosphingolipids, such as galabiosylceramide and blood group B substances to ceramide dihexoside and galactose.
Note
FABRAZYME 5 mg/ml Powder for Concentrate for Solution for Infusion manufactured by BAYER CONSUMER CARE. Its generic name is Agalsidase beta. FABRAZYME is availble in Saudi Arabia.
Farmaco SA drug index information on FABRAZYME Powder for Concentrate for Solution for Infusion is not intended for diagnosis, medical advice or treatment; neither intended to be a substitute for the exercise of professional judgment.